Literature DB >> 5645862

Suppression of glycine-15N incorporation into urinary uric acid by adenine-8-13C in normal and gouty subjects.

J E Seegmiller, J R Klinenberg, J Miller, R W Watts.   

Abstract

Adenine inhibited the de novo synthesis of purines in both normal and gouty man as shown by inhibition of the incorporation of glycine-(15)N into urinary uric acid without altering the incorporation of glycine-(15)N into urinary creatinine. The diminished purine synthesis did not result in a diminution in the 24 hr excretion of uric acid. This observation was explainable in part by the prompt conversion of adenine to uric acid. In addition to this direct conversion, adenine-8-(13)C provided a slow and prolonged contribution to urinary uric acid.A feedback inhibition of purine synthesis by nucleotides derived from adenine provides the best interpretation of these results.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5645862      PMCID: PMC297271          DOI: 10.1172/JCI105808

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  THE ENZYMOLOGY OF FEEDBACK INHIBITION OF GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE BY PURINE RIBONUCLEOTIDES.

Authors:  C T CASKEY; D M ASHTON; J B WYNGAARDEN
Journal:  J Biol Chem       Date:  1964-08       Impact factor: 5.157

2.  REGULATION OF PURINE RIBONUCLEOTIDE SYNTHESIS BY END PRODUCT INHIBITION. THE EFFECT OF ADENINE AND GUANINE RIBONUCLEOTIDES ON THE 5'-PHOSPHORIBOSYL-PYROPHOSPHATE AMIDOTRANSFERASE OF AEROBACTER AEROGENES.

Authors:  D P NIERLICH; B MAGASANIK
Journal:  J Biol Chem       Date:  1965-01       Impact factor: 5.157

3.  Feedback inhibition of purine biosynthesis in ascites tumor cells.

Authors:  J F HENDERSON
Journal:  J Biol Chem       Date:  1962-08       Impact factor: 5.157

4.  Uric acid production in gout.

Authors:  J E SEEGMILLER; A I GRAYZEL; L LASTER; L LIDDLE
Journal:  J Clin Invest       Date:  1961-07       Impact factor: 14.808

5.  The enzymatic spectrophotometric method for determination of uric acid.

Authors:  L LIDDLE; J E SEEGMILLER; L LASTER
Journal:  J Lab Clin Med       Date:  1959-12

6.  Adenine intoxication in relation to in vivo formation and deposition of 2,8-dioxyadenine in renal tubules.

Authors:  F S PHILIPS; J B THIERSCH; A BENDICH
Journal:  J Pharmacol Exp Ther       Date:  1952-01       Impact factor: 4.030

7.  Incorporation of glycine nitrogen into uric acid in normal and gouty man.

Authors:  J D BENEDICT; M ROCHE; T F YU; E J BIEN; A B GUTMAN; D STETTEN
Journal:  Metabolism       Date:  1952-01       Impact factor: 8.694

8.  Some factors influencing nucleic acid purine renewal in the rat.

Authors:  R ABRAMS
Journal:  Arch Biochem Biophys       Date:  1951-10       Impact factor: 4.013

9.  A specific enzyme defect in gout associated with overproduction of uric acid.

Authors:  W N Kelley; F M Rosenbloom; J F Henderson; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

10.  Xanthine oxidase activity in human tissues and its inhibition by allopurinol (4-hydroxypyrazolo[3,4-d] pyrimidine).

Authors:  R W Watts; J E Watts; J E Seegmiller
Journal:  J Lab Clin Med       Date:  1965-10
View more
  10 in total

1.  Contributions of Lesch-Nyhan syndrome to the understanding of purine metabolism.

Authors:  J E Seegmiller
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

2.  Gout and its relation to lipid metabolism. I. Serum uric acid, lipid, and lipoprotein levels in gout.

Authors:  H Mielants; E M Veys; A de Weerdt
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

3.  A reappraisal of the concept of an abnormality of glutamine metabolism in primary gout.

Authors:  J B Wyngaarden; O Sperling; F Starmer
Journal:  Trans Am Clin Climatol Assoc       Date:  1973

4.  Hyperuricaemia: some biochemical aspects.

Authors:  R W Watts
Journal:  Proc R Soc Med       Date:  1969-08

5.  Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.

Authors:  M A Becker
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

Review 6.  Clinical and biochemical aspects of uric acid overproduction.

Authors:  J García Puig; F A Mateos
Journal:  Pharm World Sci       Date:  1994-04-15

7.  Mechanism of excessive purine biosynthesis in hypoxanthine-guanine phosphoribosyltransferase deficiency.

Authors:  L B Sorensen
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

8.  Overproduction of uric acid in hypoxanthine-guanine phosphoribosyltransferase deficiency. Contribution by impaired purine salvage.

Authors:  N L Edwards; D Recker; I H Fox
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

9.  The kinetics of intramolecular distribution of 15N in uric acid after administration of (15N) glycine. A reappraisal of the significance of preferential labeling of N-(3+9) of uric acid in primary gout.

Authors:  O Sperling; J B Wyngaarden; C F Starmer
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

10.  Current concepts of hyperuricemia and gout.

Authors:  J R Klinenberg
Journal:  Calif Med       Date:  1969-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.